Study of GDX012 in Patients With MRD Positive AML

NCT05001451 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped This was a business decision to discontinue this clinical trial. The decision is not related to the safety of the investigational product, GDX012.

Conditions

Interventions

Sponsor

GammaDelta Therapeutics Limited